Price $165.40 |
Market Cap
256.87B
|
Sector Health Care |
Div. Growth
7.10%
|
|
P/E
20.5
|
P/B
17.55
|
P/S
4.48
|
Dividend %
4.10%
|
|
P/CF
-
|
P/FCF
20.5
|
Op. Cash Flow
22.81M
|
FCF
7.0
|
|
Op. Margin
32.30%
|
Net Margin
21.60%
|
ROE
82.80%
|
ROI
17.90%
|
|
ROA
8.50%
|
EPS Growth
87.90%
|
Current Ratio
0.8
|
Debt/Equity
416.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Psychemedics Corp. (PMD) | $5.58 | - | 4.30% | 36.4M | Strong Buy |
| Helius Medical Technologies In (HSDT) | $0.26 | - | - | 7.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.61 | - | - | 105.8M | Strong Buy |
| Greenrose Holding Company Inc (GNRS) | $0.37 | - | - | 18.6M | Strong Buy |
| Great Elm Group Inc (GEG) | $1.98 | - | - | 59.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
